파킨슨병 세포치료를 위한 줄기세포 이용 현황
유대훈, 송슬애, 조명수 · 인구의학연구논집 · 2013
Parkinson`s disease (PD) is the second most prevalent neurodegenerative disease, next to Alzheimer`s disease, affecting approximately 0.5% of 65-69 year old adults. PD is a characterized by a progressive degeneration and loss of dopaminergic neurons within the substantia nigra pars compacta, leading to the classical symptoms of the disease, such as tremor, rigidity, and hypokinesia. Stem cells have a high capacity for self-renewal and differentiation potential and some of them can be differentiated into dopaminergic neurons on specific conditions. However, there are some postulations for clinical application of the stem cell-derived dopaminergic neurons. The stem cells grafts should exhibit a regulated release of dopamine and molecular, electrophysiological, and morphological properties similar to those of substantia nigra neurons, reestablish the dopamine network within the striatum and restore the functional connectivity with host extra-striatal neural circuitries and produce no adverse-effects such as tumor formation, immune reactions and graft-induced dyskinesias. In this review, we described the advantages and disadvantages of each characeteristic of variable stem cells with regard to its potential use for PD treatment.
Cited by 0 works.